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Inclusion criteria (List criteria such as age groups, study designs, to be included)
Humans, rctc, cohort, observational, case series Exclusion criteria (List criteria such as study designs, to be excluded) Of 4 studies evaluating IHF, one RCT 9 reported a significant improvement in LVEDV but not in LVESV; 2 single arm studies 10, 11 reported a significant improvement in both LVEDV and LVESV, and one single arm study 12 showed an improvement in LVESV only.
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Appendix 8c. Wall motion
Wall motion was assessed in 6 studies 1, [3] [4] [5] [6] 12 that were included in a meta-analysis and there was no significant difference in wall motion between MSC and control (SMD 0.00, 95% CI -0.36 -0.36, I 2 =58.6%) (Appendix 7, Figure 7c ). One study reported significant difference in mean percent change in wall motion from baseline to 6 months between MSC and standard treatment (p=0.73). 13 alone study reported no significant differences in wall motion score index between MSC and placebo. 
5
Objectives 4 Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).

METHODS
Protocol and registration 5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.
6
Eligibility criteria 6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.
Information sources 7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.
6 Search 8 Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.
Study selection 9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).
8
Data collection process 10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.
Data items 11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made. 
